Featured Articles

Selective Ablation of Tumorigenic Cells Following Human Induced Pluripotent Stem Cell‐Derived Neural Stem/Progenitor Cell Transplantation in Spinal Cord Injury

Given the nature of stem cell therapy, it is impossible to be certain that a tumorigenic transformation will not occur following transplantation. However, clinicians/scientists are duty‐bound to tackle the issue from multiple angles, working toward clinical implementation of this novel technology. Previous studies, aiming to tackle tumorigenesis after the transplantation has been performed, involved the eradication of all of the transplanted cells and the loss of the improved motor function as a result. This new approach, however, allows us to both prevent and treat tumorigenesis that occur post‐transplantation without sacrificing the improved motor function which is definitely an improvement worth noting.